Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Xtant Medical Holdings, Inc. Common Stock (NY:XTNT)

0.5600 -0.0130 (-2.27%)
Official Closing Price Updated: 6:30 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Xtant Medical Holdings, Inc. Common Stock

< Previous 1 2 3 Next >
Xtant Medical Partners With B2i Digital to Educate Investors on Its Orthobiologics Innovation and Market Opportunity
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Xtant Medical Partners With B2i Digital to Educate Investors on Its Orthobiologics Innovation and Market Opportunity
Via TheNewswire.com
Get insights into the top gainers and losers of Wednesday's pre-market session.
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
Companion Spine LLC Announces Definitive Agreement to Acquire the Business and Assets of Paradigm Spine GmbH and the Coflex® and CoFix® Spine Implants from Xtant™ Medical Holdings, Inc.
From Companion Spine
Via Business Wire
Earnings Scheduled For May 12, 2025
 
Via Benzinga
A Glimpse of Xtant Medical Hldgs's Earnings Potential
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Stay updated with the stocks that are on the move in today's after-hours session.
The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Xtant Medical Reports Fourth Quarter and Full Year 2024 Financial Results
Via ACCESS Newswire
Xtant Medical Reports Third Quarter 2024 Financial Results
Via ACCESSWIRE
Earnings Scheduled For November 12, 2024
 
Via Benzinga
Xtant Medical Hldgs's Earnings Outlook
 
Via Benzinga
Xtant Medical Expands Product Portfolio with the Launch of the Cortera(R) Posterior Fixation System
Via ACCESSWIRE
Earnings Scheduled For March 6, 2025
 
Via Benzinga
Xtant Medical Expands Product Portfolio with Launch of its own Viable Bone Matrix, OsteoVive(R) Plus
Via ACCESSWIRE
Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue Guidance
Via ACCESSWIRE
Xtant Medical to Issue Fourth Quarter and Year End 2024 Financial Results on March 6, 2025
Via ACCESS Newswire
Xtant Medical to Attend the 15th Annual Craig-Hallum Alpha Select Conference
Via ACCESSWIRE
Xtant Medical to Issue Third Quarter 2024 Financial Results on November 12, 2024
Via ACCESSWIRE
XTNT Stock Earnings: Xtant Medical Hldgs Misses EPS, Beats Revenue for Q2 2024
XTNT stock results show that Xtant Medical Hldgs missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Xtant Medical Announces $5.0 Million Private Placement
Via ACCESSWIRE
Xtant Medical to Host Second Quarter 2024 Financial Results Earnings Conference call on August 9, 2024
Via ACCESSWIRE
Xtant Medical Reports Second Quarter 2024 Revenue Growth of 48%
Via ACCESSWIRE
Xtant Medical to Present at the Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Xtant Medical to Participate in 21st Annual Craig-Hallum Institutional Investor Conference on May 29
Via ACCESSWIRE
XTNT Stock Earnings: Xtant Medical Hldgs Misses EPS, Beats Revenue for Q1 2024
XTNT stock results show that Xtant Medical Hldgs missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024
Via ACCESSWIRE
XTNT Stock Earnings: Xtant Medical Hldgs Misses EPS, Beats Revenue for Q4 2023
XTNT stock results show that Xtant Medical Hldgs missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.